DOP2003000642A - Derivados de hidroxi tetrahidro-naftalenilurea - Google Patents
Derivados de hidroxi tetrahidro-naftalenilureaInfo
- Publication number
- DOP2003000642A DOP2003000642A DO2003000642A DO2003000642A DOP2003000642A DO P2003000642 A DOP2003000642 A DO P2003000642A DO 2003000642 A DO2003000642 A DO 2003000642A DO 2003000642 A DO2003000642 A DO 2003000642A DO P2003000642 A DOP2003000642 A DO P2003000642A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- pain
- derivatives
- tetrahydro
- useful
- naftalenilurea
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- GYUVMUDBAKAYON-UHFFFAOYSA-N 1-hydroxy-1-(1,2,3,4-tetrahydronaphthalen-1-yl)urea Chemical class C1=CC=C2C(N(O)C(=O)N)CCCC2=C1 GYUVMUDBAKAYON-UHFFFAOYSA-N 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2003000642A true DOP2003000642A (es) | 2003-11-15 |
Family
ID=9936269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2003000642A DOP2003000642A (es) | 2002-05-08 | 2003-05-07 | Derivados de hidroxi tetrahidro-naftalenilurea |
Country Status (13)
| Country | Link |
|---|---|
| KR (1) | KR101000688B1 (fr) |
| AR (1) | AR039983A1 (fr) |
| CU (1) | CU23422B7 (fr) |
| DO (1) | DOP2003000642A (fr) |
| EC (1) | ECSP045413A (fr) |
| GB (2) | GB0210512D0 (fr) |
| GT (1) | GT200300102A (fr) |
| MA (1) | MA30728B1 (fr) |
| MY (1) | MY155011A (fr) |
| PE (1) | PE20040363A1 (fr) |
| PT (1) | PT1506167E (fr) |
| UA (1) | UA77301C2 (fr) |
| ZA (1) | ZA200408993B (fr) |
-
2002
- 2002-05-08 GB GBGB0210512.0A patent/GB0210512D0/en not_active Ceased
- 2002-11-21 GB GBGB0227262.3A patent/GB0227262D0/en not_active Ceased
-
2003
- 2003-04-28 UA UA20041210079A patent/UA77301C2/uk unknown
- 2003-04-28 PT PT03722554T patent/PT1506167E/pt unknown
- 2003-04-28 KR KR1020047017969A patent/KR101000688B1/ko not_active Expired - Fee Related
- 2003-05-05 GT GT200300102A patent/GT200300102A/es unknown
- 2003-05-06 MY MYPI20031696A patent/MY155011A/en unknown
- 2003-05-07 DO DO2003000642A patent/DOP2003000642A/es unknown
- 2003-05-07 PE PE2003000445A patent/PE20040363A1/es not_active Application Discontinuation
- 2003-05-08 AR ARP030101614A patent/AR039983A1/es active IP Right Grant
-
2004
- 2004-11-04 CU CU20040254A patent/CU23422B7/es unknown
- 2004-11-05 MA MA27935A patent/MA30728B1/fr unknown
- 2004-11-05 ZA ZA2004/08993A patent/ZA200408993B/en unknown
- 2004-11-08 EC EC2004005413A patent/ECSP045413A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1506167E (pt) | 2007-12-10 |
| KR101000688B1 (ko) | 2010-12-10 |
| GB0227262D0 (en) | 2002-12-31 |
| KR20040108784A (ko) | 2004-12-24 |
| CU23422B7 (es) | 2009-09-08 |
| MA30728B1 (fr) | 2009-10-01 |
| ECSP045413A (es) | 2005-01-03 |
| PE20040363A1 (es) | 2004-07-03 |
| GT200300102A (es) | 2004-03-17 |
| MY155011A (en) | 2015-08-28 |
| GB0210512D0 (en) | 2002-06-19 |
| UA77301C2 (en) | 2006-11-15 |
| AR039983A1 (es) | 2005-03-09 |
| ZA200408993B (en) | 2006-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE370118T1 (de) | Tetrahydronaphtalen-derivate | |
| GT200200272A (es) | Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino] quinazolin-6-il} alil)acetamidayprocedimiento para la produccion | |
| AR058679A1 (es) | Preparacion farmaceutica que contiene meloxicam | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| DOP2003000565A (es) | Esteres hidroxamato del acido n-(4-fenil sustituido)- antranilico | |
| ECSP045228A (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| WO2003055848A3 (fr) | Derives d'uree | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| CR20210686A (es) | Análogos de 3–(5–metil–1,3–tiazol–2–il)–n–{(1r)–1–[2–(trifluor–metil)pirimidin–5–il]etil}benzamida | |
| UY27657A1 (es) | Derivados de nicotinamida útiles como inhibidores de pde4 | |
| UY27725A1 (es) | Material micronizado cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento. | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| WO2011056033A3 (fr) | Composition pharmaceutique pour prévenir ou traiter des maladies associées à l'activité trpv1 ou des maladies ou affections associées à l'inflammation, contenant un peptide de maillard séparé de sauce de soja traditionnelle correctement vieillie en tant que substance active | |
| UY28702A1 (es) | Derivados de quinazolina | |
| AR065317A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| WO2004100893A3 (fr) | Methodes de traitement d'affections inflammatoires a l'aide de ct-3 ou de ses analogues | |
| AR081253A1 (es) | Uso de la tierra de diatomeas en la industria farmaceutica | |
| GT200200249A (es) | Composicion herbicida | |
| UY27794A1 (es) | Derivados de hidroxi tetrahidro-naftalenilurea | |
| DE602006009259D1 (de) | Pharmazeutische zusammensetzung mit einem organopoirkstoff | |
| ECSP045413A (es) | "derivados de hidroxi-tetrahidro-naftalenilurea" | |
| UY27670A1 (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y de agentes inhibidores de la cinasa del egfr | |
| AR029639A1 (es) | Amidas sustituidas del acido fenilciclohexanocarboxilico, procedimiento para su preparacion, compuestos intermediarios, medicamentos, y el uso para la manufactura de un medicamento utiles como inhibidores de la incorporacion de adenosina | |
| WO2012060594A3 (fr) | Composition anti-inflammatoire contenant un composé thiourée et un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif |